DCGI grants approval to Corbevax for kids aged 5-12, Covaxin for 6-12 age group

The Drug Controller General of India (DCGI) on Tuesday granted emergency use approval to Covid-19 vaccines, Covaxin and Corbevax, for children below 12. Bharat Biotech's Covaxin has got nod for use in children in the age group of 6-12, while Biological E's Corbevax can be administered ​​to children aged 5-12. The apex drug regulator has also given nod to Pharma major Zydus Cadila's ZyCov-D vaccine for use in children above 12 years.

from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/x5sOt7W

Newer Post Older Post